The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Sales volume of leading products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2023 (in units)
Sales volume of major products of Fosun Pharmaceutical 2023
In 2023, the Chinese pharmaceutical firm Fosun Pharmaceutical sold more than *** units of Han Qu You (trastuzumab), more than all other pharmaceutical products. The company sold more than units of Comirnaty, one of the most popular mRNA COVID-19 vaccines in 2022.
Log in or register to access precise data.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Yiling Pharmaceutical's advertising and promotion expenses 2013-2022
- Premium Statistic Revenue breakdown of Fosun Pharmaceutical 2022, by location
- Premium Statistic Pharmaceutical manufacturing segment gross profit of Fosun Pharmaceutical 2019-2022
- Premium Statistic Pharmaceutical manufacturing segment revenue of Fosun Pharmaceutical 2019-2022
- Premium Statistic Revenue breakdown of Fosun Pharmaceutical 2022, by business segment
- Premium Statistic R&D expense revenue share of selected Chinese pharma companies 2022
- Premium Statistic R&D spending of Fosun Pharmaceutical 2019-2022
- Premium Statistic Market share of cardiovascular internal drugs in China 2015-H1 2022
- Premium Statistic Total assets of Fosun Pharmaceutical 2019-2022
- Premium Statistic Share of R&D staff in the whole workforce of Fosun Pharmaceutical 2019-2022
About the region
10
- Premium Statistic Number of R&D staff in Fosun Pharmaceutical 2019-2022
- Premium Statistic Gross profit of Fosun Pharmaceutical 2019-2022
- Premium Statistic R&D expense revenue share of Fosun Pharmaceutical 2019-2022
- Premium Statistic Operating profit of Fosun Pharmaceutical 2019-2022
- Premium Statistic Market share of Lianhua Qingwen in public healthcare in China H1 2022
- Premium Statistic Advertising and promotion expenses of Yunnan Baiyao Group 2017-2022
- Premium Statistic Advertising and promotion expenses of Guangzhou Baiyunshan Pharmaceutical 2013-2023
- Premium Statistic Market share of major cardiovascular internal drugs in China H1 2022
- Premium Statistic Market share of Lianhua Qingwen in retail market in China 2022
- Premium Statistic R&D expense of selected Chinese pharma companies 2022
Selected statistics
10
- Premium Statistic Number of pharmaceutical manufacturing companies in Hungary 2010-2023
- Premium Statistic Net sales of Abdi Ibrahim Ilaç San. ve Tic. A.S. 2015-2024
- Premium Statistic Net sales of Koçak Farma Ilaç ve Kimya Sanayi A.S. 2015-2024
- Basic Statistic Net sales of Deva Holding A.S. 2015-2024
- Premium Statistic Sales volume of medicinal products in Turkey 2015-2024
- Premium Statistic Pharmaceutical volume in Italy in 2023, by reimbursable or non-reimbursable drugs
- Basic Statistic Pharmaceutical product innovation expenditure in Germany 2008-2025
- Premium Statistic Distribution of pharmaceutical products Thailand 2023, by channel
- Premium Statistic Leaders in the pharmaceutical drug industry in Romania Q2 2024, by revenue
- Premium Statistic Number of employees in R&D of pharmaceuticals companies in Italy 2008-2022
Other regions
10
- Basic Statistic Number of applications for drug reimbursement in Denmark 2013-2022
- Premium Statistic Change in prices of pharmaceutical sold production in Poland 2010-2023
- Basic Statistic Number of declined drug reimbursement applications in Denmark 2013-2022
- Basic Statistic Number of approved drug reimbursement applications in Denmark 2013-2022
- Premium Statistic Investment of pharma manufacturing in intellectual property in Italy 2010-2021
- Basic Statistic Profits of pharmaceutical company GlaxoSmithKline Consumer Nigeria 2020
- Premium Statistic Profits of the Nigerian pharmaceutical company Pharma Deko 2020
- Basic Statistic Profits of Nigerian company Union Diagnostic Clinical Services 2020
- Basic Statistic Profits of Nigerian pharmaceutical company Morison Industries 2020
- Basic Statistic Profit of the chemical company May & Baker Nigeria 2020
Related statistics
10
- Basic Statistic Profits of Nigerian pharmaceutical company Ekocorp 2020
- Premium Statistic Funding for human papillomavirus (HPV) research and development (R&D) worldwide 2018
- Premium Statistic Funding for contraception research and development (R&D) worldwide in 2018
- Premium Statistic Foreign partnership in China's pharma industry 2013-2021
- Premium Statistic Premiums for public U.S. biopharma company trade sales 2010-2019
- Premium Statistic US and European biopharma company M&A transaction volumes by type 2010-2019
- Premium Statistic US and European private VC-backed orphan biopharma company M&A values 2014-2019
- Premium Statistic China's Shanghai Pharmaceuticals sales volume 2021, by product
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Premium Statistic Venezuela: pharma industry market value 2008-2017
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Shanghai Fosun Pharmaceutical (Group). (March 26, 2024). Sales volume of leading products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2023 (in units) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 31, 2026, from /statistics/1405759/fosun-pharmaceutical-sales-volume-of-major-products/
Shanghai Fosun Pharmaceutical (Group). "Sales volume of leading products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2023 (in units)." Chart. March 26, 2024. ÌÇÐÄÆƽâ°æ. Accessed July 31, 2026. /statistics/1405759/fosun-pharmaceutical-sales-volume-of-major-products/
Shanghai Fosun Pharmaceutical (Group). (2024). Sales volume of leading products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2023 (in units). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 31, 2026. /statistics/1405759/fosun-pharmaceutical-sales-volume-of-major-products/
Shanghai Fosun Pharmaceutical (Group). "Sales Volume of Leading Products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2023 (in Units)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 26 Mar 2024, /statistics/1405759/fosun-pharmaceutical-sales-volume-of-major-products/
Shanghai Fosun Pharmaceutical (Group), Sales volume of leading products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2023 (in units) ÌÇÐÄÆƽâ°æ, /statistics/1405759/fosun-pharmaceutical-sales-volume-of-major-products/ (last visited July 31, 2026)
Sales volume of leading products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2023 (in units) [Graph], Shanghai Fosun Pharmaceutical (Group), March 26, 2024. [Online]. Available: /statistics/1405759/fosun-pharmaceutical-sales-volume-of-major-products/
Advertisement